Was todays ardm announcement good news or bad news?
Here's yet another inhaled insulin company. Isn't Mankind the name of a world wrestler? No doubt named after someone named Mann. Add it to the list of cheesy biotech names :-)
Reuters
UPDATE - Biopharmaceutical firm MannKind files for IPO
Friday April 30, 8:34 am ET
(Adds details)
WASHINGTON, April 30 (Reuters) - MannKind Corp., a biopharmaceutical firm focused on treatments for diabetes, cancer and autoimmune diseases, on Friday filed with the U.S. Securities and Exchange Commission (News - Websites) to go public.
The Valencia, California-based company filed a preliminary offering document for as much as $86.25 million in common stock but did not specify the number of shares or the price for the IPO, as those details are expected in future filings.
UBS Investment Bank, Piper Jaffray, Wachovia Securities, Jefferies & Co. Inc. and Harris Nesbitt Gerard are listed in the prospectus as the underwriters.
It is seeking a Nasdaq listing under the symbol "MNKD."
The company said it plans to use the proceeds from the IPO for developing its dry powder insulin that is inhaled, working capital and other general corporate purposes. |
